The Happy Lungs Project presents our 2025 RET Research Update
For the fourth year, HLP will hold its annual RET Research Update, a virtual webinar at which HLP grantees will share results on previously funded research and an early view of what’s next for RET.
In addition to RET investigators, this year, for the first time ever, patients will have the opportunity to hear directly from our pharmaceutical partners:
-
Eli Lilly Pharmaceutical Company (Selpercatinib)
-
Rigel Pharmaceuticals (Pralsetinib)
-
Ellipses Pharma (EP0031)
We’ll also present the first update on the Lung Cancer Genetics Study, a collaboration between the lung cancer community, Troper Wojcicki Philanthropies, and the 23andMe Research Institute.
Thursday, December 11
12:30pm – 2:30pm CT
Questions or need more information? Contact us at info@happylungsproject.org
